ENSPRYNG is Japan’s first and only approved therapy for both adults and children with neuromyelitis optica…
<< Japan
Novartis receives simultaneous approval for five new products from Japanese Ministry of Health, Labour and Welfare, offering Japanese patients a broad range of novel treatment options
Basel, June 29, 2020 — Novartis Pharma K.K. (“Novartis Pharma”) today announced that the Japanese Ministry of…
GSK receives first regulatory approval for Duvroq (daprodustat) in Japan for patients with anaemia due to chronic kidney disease
Approval marks a significant step in GSK’s global efforts to help patients with anaemia due to…
Hitachi and Microsoft form a strategic alliance to advance next-generation digital solutions for manufacturing and logistics across Southeast Asia, North America and Japan
Tokyo, June 25, 2020 — Hitachi, Ltd. and Microsoft Corp. on Thursday announced a multiyear strategic alliance…
Bvlgari and Moët Hennessy Diageo help fight coronavirus in Japan
Like other countries around the world, Japan is facing the unprecedented health crisis triggered by the…
Cisco Powers Rakuten Mobile’s Inter-network Roaming Service Launch to Help Customers Stay Seamlessly Connected From One Mobile Network to Another
The home-routed roaming service based on the S10 interface will be rolled out across Rakuten Mobile…
Mattel Celebrates Olympic Games Tokyo 2020 Products Collection
EL SEGUNDO, Calif., February 18, 2020 — Mattel, Inc. (NASDAQ: MAT) today revealed their first products collection across…
Louis Vuitton celebrates unique ties with Japan with opening of new flagship in Osaka
Louis Vuitton inaugurated its new Louis Vuitton Maison Osaka Midosuji flagship store on February 1st. Designed in…
Allianz enters JV agreement with AEON Financial Service
Allianz SE has entered into an agreement to form a life insurance joint venture (JV) with…
Bayer receives approval for darolutamide in Japan
Marketing authorization granted for the treatment of men with non-metastatic castration-resistant prostate cancer Berlin, January 23,…